These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20857961)

  • 41. On structural transitions in a discontinuous micellar cubic phase loaded with sodium diclofenac.
    Efrat R; Aserin A; Garti N
    J Colloid Interface Sci; 2008 May; 321(1):166-76. PubMed ID: 18279886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assembly of polyethyleneimine in the hexagonal mesophase of nonionic surfactant: effect of pH and temperature.
    Sharma KP; Choudhury CK; Srivastava S; Davis H; Rajamohanan PR; Roy S; Kumaraswamy G
    J Phys Chem B; 2011 Jul; 115(29):9059-69. PubMed ID: 21696191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the phase behaviour of a novel polymerizable lyotropic ionic liquid crystal.
    Goujon N; Forsyth M; Dumée LF; Bryant G; Byrne N
    Phys Chem Chem Phys; 2015 Sep; 17(35):23059-68. PubMed ID: 26271610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and mesophases of glycerate surfactants.
    Fong C; Wells D; Krodkiewska I; Booth J; Hartley PG
    J Phys Chem B; 2007 Feb; 111(6):1384-92. PubMed ID: 17286353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of glycerol and phosphatidylcholine in solubilizing and enhancing insulin stability in reverse hexagonal mesophases.
    Amar-Yuli I; Azulay D; Mishraki T; Aserin A; Garti N
    J Colloid Interface Sci; 2011 Dec; 364(2):379-87. PubMed ID: 21958442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems.
    Yariv D; Efrat R; Libster D; Aserin A; Garti N
    Colloids Surf B Biointerfaces; 2010 Jul; 78(2):185-92. PubMed ID: 20363601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior.
    Dong YD; Dong AW; Larson I; Rappolt M; Amenitsch H; Hanley T; Boyd BJ
    Langmuir; 2008 Jun; 24(13):6998-7003. PubMed ID: 18522450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nematic DNA Thermotropic Liquid Crystals with Photoresponsive Mechanical Properties.
    Zhang L; Maity S; Liu K; Liu Q; Göstl R; Portale G; Roos WH; Herrmann A
    Small; 2017 Sep; 13(34):. PubMed ID: 28696523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concentration- and temperature-induced effects of incorporated desmopressin on the properties of reverse hexagonal mesophase.
    Libster D; Aserin A; Yariv D; Shoham G; Garti N
    J Phys Chem B; 2009 May; 113(18):6336-46. PubMed ID: 19358543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tuning in-meso-crystallized lysozyme polymorphism by lyotropic liquid crystal symmetry.
    Zabara A; Amar-Yuli I; Mezzenga R
    Langmuir; 2011 May; 27(10):6418-25. PubMed ID: 21506575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmaceutical liquid crystals: the relevance of partially ordered systems.
    Stevenson CL; Bennett DB; Lechuga-Ballesteros D
    J Pharm Sci; 2005 Sep; 94(9):1861-80. PubMed ID: 16052511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liquid crystalline phases and their dispersions in aqueous mixtures of glycerol monooleate and glyceryl monooleyl ether.
    Popescu G; Barauskas J; Nylander T; Tiberg F
    Langmuir; 2007 Jan; 23(2):496-503. PubMed ID: 17209599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology.
    Shah RB; Zidan AS; Funck T; Tawakkul MA; Nguyenpho A; Khan MA
    Int J Pharm; 2007 Aug; 341(1-2):189-94. PubMed ID: 17521836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polarization transfer solid-state NMR for studying surfactant phase behavior.
    Nowacka A; Mohr PC; Norrman J; Martin RW; Topgaard D
    Langmuir; 2010 Nov; 26(22):16848-56. PubMed ID: 20925371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thermally induced fluid reversed hexagonal (H(II)) mesophase.
    Amar-Yuli I; Wachtel E; Shalev DE; Moshe H; Aserin A; Garti N
    J Phys Chem B; 2007 Dec; 111(48):13544-53. PubMed ID: 17988117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. pH-responsive lyotropic liquid crystals and their potential therapeutic role in cancer treatment.
    Negrini R; Fong WK; Boyd BJ; Mezzenga R
    Chem Commun (Camb); 2015 Apr; 51(30):6671-4. PubMed ID: 25783035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Head group effects on molecular packing in lamellar liquid crystals.
    Ishizuka C; Arima S; Aramaki K
    J Colloid Interface Sci; 2011 Sep; 361(1):148-53. PubMed ID: 21652048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. pH-responsive lyotropic liquid crystals for controlled drug delivery.
    Negrini R; Mezzenga R
    Langmuir; 2011 May; 27(9):5296-303. PubMed ID: 21452814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural rearrangements and interaction within H(II) mesophase induced by cosolubilization of vitamin E and ascorbic acid.
    Bitan-Cherbakovsky L; Yuli-Amar I; Aserin A; Garti N
    Langmuir; 2009 Nov; 25(22):13106-13. PubMed ID: 19852480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.
    Garti N; Libster D; Aserin A
    Food Funct; 2012 Jul; 3(7):700-13. PubMed ID: 22592749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.